By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Marinus Pharmaceuticals 

21 Business Park Drive

Branford  Connecticut  06405  U.S.A.
Phone: 203-315-0566 Fax: 203-315-0565


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
Marinus Pharma (MRNS) Release: Ganaxolone Reduces Seizures And Improves Behaviors in Angelman Syndrome Preclinical Model 2/14/2017 11:17:03 AM
Marinus Pharma (MRNS) Appoints Michael R. Dougherty To Its Board Of Directors 2/1/2017 7:33:52 AM
Marinus Pharma (MRNS) Release: Troubled Biotech Finally Gets Some Positive Trial Data 1/23/2017 6:56:18 AM
Marinus Pharma (MRNS) Receives FDA Orphan Drug Designation For Ganaxolone To Treat Fragile X Syndrome 1/3/2017 8:07:54 AM
Marinus Pharma (MRNS) Release: Ganaxolone and Diazepam Administered Intravenously Synergistically Block Seizures In Animal Model Of Status Epilepticus 11/15/2016 9:26:04 AM
Marinus Pharma (MRNS) Provides Business Update And Reports Third Quarter 2016 Financial Results 11/3/2016 9:07:18 AM
Marinus Pharma (MRNS) Release: Ganaxolone Phase I Data Supports Progressing To Phase II In Patients With Status Epilepticus 10/19/2016 8:10:48 AM
Marinus Pharma (MRNS) Release: Ganaxolone Reduces Seizures In Females With PCDH19 Pediatric Epilepsy 9/29/2016 11:08:10 AM
Marinus Pharma (MRNS) Appoints Seth H.Z. Fischer To Its Board Of Directors 9/7/2016 9:01:49 AM
Marinus Pharma (MRNS)'s Stock Plummets as Seizure Drug Flunks Phase III Study 6/13/2016 6:24:29 AM
123456
//-->